cardiac attack. Acute myocardial infarction
Conditions
Interventions
Intervention 1: A group treated with integtilin performed immediately before angioplasty. Dose of 180 micrograms per kg body weight integriln unit dosage form is administered before angioplasty follow
Treatment - Drugs
A group treated with integtilin performed immediately before angioplasty. Dose of 180 micrograms per kg body weight integriln unit dosage form is administered before angioplasty followed by a second 1
Group B treated with coronary angioplasty are useful to the common method
Sponsors
Vice chancellor for research, Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1. Included all patients who present with typical chest pain and their ECG have ST-Elevation changes (less than 6 hours of onset of symptoms, patients should be referred to the emergency room). If patient is admitted between 6 to 12 hours from onset of symptoms and still have chest pain with the st-elevation changes in EKG ,are said to be in the study 2. patients do not have integrilin drug contraindications. Exclusion criteria: 1. patients with Coagulopathic bleeding disorders 2. delay time of 12 hours of pain onset to admission. 3. active bleeding 4. in group A: active bleeding, recent major surgery within 6 weeks, platelet count less than 100000, severe hypertension (> 200/110 mm/Hg), history of stroke or hemorrhagic stroke within 30 days, renal failure
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ejection fraction. Timepoint: One month later. Method of measurement: Echocardiography.;EKG changes. Timepoint: one month later. Method of measurement: EKG.;Ejection fraction. Timepoint: three months later. Method of measurement: Echocardiography.;EKG changes. Timepoint: three months later. Method of measurement: EKG. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality. Timepoint: one month and three months latar. Method of measurement: Total death toll. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBehfar Pakbaz
Arak University of Medical Science
Outcome results
None listed